Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Mesa Laboratories, Inc. (MLAB : NSDQ)
 
 • Company Description   
MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy.

Number of Employees: 730

 
 • Price / Volume Information   
Yesterday's Closing Price: $94.22 Daily Weekly Monthly
20 Day Moving Average: 211,329 shares
Shares Outstanding: 5.46 (millions)
Market Capitalization: $514.01 (millions)
Beta: 0.86
52 Week High: $155.12
52 Week Low: $86.04
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -3.82% -7.99%
12 Week -13.59% -29.50%
Year To Date -28.55% -32.27%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
12100 W 6TH AVE
-
LAKEWOOD,CO 80228
USA
ph: 303-987-8000
fax: 303-987-8989
investorrelations@mesalabs.com http://www.mesalabs.com
 
 • General Corporate Information   
Officers
Gary M. Owens - Chief Executive Officer; President; and Director
John J. Sullivan - Chairman of the Board of Directors
John V. Sakys - Chief Financial Officer and Chief Accounting Offic
Jennifer S. Alltoft - Director
Mark C. Capone - Director

Peer Information
Mesa Laboratories, Inc. (ABMD)
Mesa Laboratories, Inc. (DMDS)
Mesa Laboratories, Inc. (CPWY.)
Mesa Laboratories, Inc. (EQUR)
Mesa Laboratories, Inc. (ECIA)
Mesa Laboratories, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 59064R109
SIC: 3823
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/04/25
Share - Related Items
Shares Outstanding: 5.46
Most Recent Split Date: (:1)
Beta: 0.86
Market Capitalization: $514.01 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.68%
Current Fiscal Quarter EPS Consensus Estimate: $1.83 Indicated Annual Dividend: $0.64
Current Fiscal Year EPS Consensus Estimate: $8.09 Payout Ratio: 0.08
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: -0.04
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 05/30/2025 - $0.16
Next EPS Report Date: 08/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 11.65
Trailing 12 Months: 12.05
PEG Ratio: -
Price Ratios
Price/Book: 3.20
Price/Cash Flow: 7.68
Price / Sales: 2.13
EPS Growth
vs. Year Ago Period: -26.67%
vs. Previous Quarter: -20.29%
Sales Growth
vs. Year Ago Period: 5.49%
vs. Previous Quarter: -1.12%
ROE
06/30/25 - -
03/31/25 - 27.51
12/31/24 - 30.23
ROA
06/30/25 - -
03/31/25 - 9.78
12/31/24 - 10.42
Current Ratio
06/30/25 - -
03/31/25 - 0.63
12/31/24 - 0.71
Quick Ratio
06/30/25 - -
03/31/25 - 0.47
12/31/24 - 0.53
Operating Margin
06/30/25 - -
03/31/25 - 17.90
12/31/24 - 19.48
Net Margin
06/30/25 - -
03/31/25 - -0.82
12/31/24 - -104.92
Pre-Tax Margin
06/30/25 - -
03/31/25 - 2.47
12/31/24 - -113.50
Book Value
06/30/25 - -
03/31/25 - 29.42
12/31/24 - 28.57
Inventory Turnover
06/30/25 - -
03/31/25 - 3.13
12/31/24 - 2.90
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.48
12/31/24 - 0.61
Debt-to-Capital
06/30/25 - -
03/31/25 - 32.49
12/31/24 - 37.92
 

Powered by Zacks Investment Research ©